Dr. Davis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 N Academy Ave
Danville, PA 17822Phone+1 570-271-7383Fax+1 570-271-7384
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1980 - 1983
- OhioHealth/Riverside Methodist HospitalResidency, Internal Medicine, 1977 - 1980
- Ohio State University College of MedicineClass of 1977
Certifications & Licensure
- PA State Medical License 2016 - 2024
- OH State Medical License 1977 - 2019
- MN State Medical License 1980 - 1983
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
- Join now to see all
Publications & Presentations
PubMed
- 3409 citationsDefinition and classification of cancer cachexia: an international consensusKenneth C. H. Fearon, Florian Strasser, Stefan D. Anker, Ingvar Bosaeus, Eduardo Bruera
The Lancet. Oncology. 2011-05-01 - 143 citationsMethadone for relief of cancer pain : a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administrationMellar P. Davis, Declan Walsh
Supportive Care in Cancer. 2001-03-01 - 76 citationsReview Article: A Systematic Review of Cancer-Related Fatigue Measurement QuestionnairesDilara Seyidova-Khoshknabi, Mellar P. Davis, Declan Walsh
The American Journal of Hospice & Palliative Care. 2011-03-01
Press Mentions
- Groundbreaking Cannabis Cancer Trial Highlights Ongoing ChallengesSeptember 19th, 2024
- Low-Dose Erlotinib Seems Feasible for Frail, Elderly Patients with NSCLCMay 26th, 2020
- Cancer Cachexia: Definitions, Outcomes, and TreatmentsDecember 17th, 2018
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: